![Vincent Ippolito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vincent Ippolito
Vorsitzender bei
BOTANIX PHARMACEUTICALS LIMITED
Vermögen: 287 862 $ am 31.05.2026
Profil
Mr. Vincent P.
Ippolito is an Executive Chairman & President at Botanix Pharmaceuticals Ltd. and an Executive Chairman & President at Botanix Pharmaceuticals, Inc. He is on the Board of Directors at Suneva Medical, Inc. Mr. Ippolito was previously employed as a President & Chief Operating Officer by Dermavant Sciences, Inc., a Chief Commercial Officer & Executive VP by Anacor Pharmaceuticals LLC, a Senior Vice President & General Manager-Aesthetics by Bausch Health Cos., Inc., a Chief Commercial Officer, EVP-Sales & Marketing by Medicis Pharmaceutical Corp., and a Vice President-Sales by Novartis AG.
He received his undergraduate degree from the University of Wisconsin-Eau Claire.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 16’668’311 ( 0.61% ) | 287 862 $ | 31.05.2026 |
Aktive Positionen von Vincent Ippolito
| Unternehmen | Position | Beginn |
|---|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Vorsitzender | 18.07.2019 |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Direktor/Vorstandsmitglied | 28.08.2017 |
Botanix Pharmaceuticals, Inc.
 Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Vorsitzender | 01.07.2019 |
Ehemalige bekannte Positionen von Vincent Ippolito
| Unternehmen | Position | Ende |
|---|---|---|
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Präsident | 01.01.2019 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 30.09.2017 |
| MEDICIS PHARMACEUTICAL CORP | Vertrieb & Marketing | 01.03.2014 |
| NOVARTIS AG | Vertrieb & Marketing | 02.01.2003 |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Ausbildung von Vincent Ippolito
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and commercializes novel, differentiated aesthetic products | Electronic Technology |
University of Wisconsin-Eau Claire
 University of Wisconsin-Eau Claire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of musculoskeletal diseases, such as oacne, psoriasis and atopic dermatitis | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
